查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球生物芯片市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测
市场调查报告书
商品编码
1307000

全球生物芯片市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测

Global Biochips Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 121 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2030年，全球生物芯片市场需求将从2022年的89.1亿美元增长至271.9亿美元，2023-2030年复合年增长率为14.97%。

生物芯片，也称为微阵列，是由微小芯片或玻璃载玻片组成的小型设备，用于研究DNA、RNA和蛋白质等生物分子。这些装置有数千至数百万个微观点，每个点含有不同的生物分子。它们的工作原理是将感兴趣的生物分子与芯片表面的光点结合，然后使用荧光、化学发光或质谱等各种方法对其进行分析。通过分析芯片上每个点的信号，研究人员可以获得被分析生物样品的大量信息。

市场动态：

个性化医疗是指根据个人的基因构成量身定制医疗方案，这一日益增长的趋势推动了对生物芯片的需求。生物芯片用于分析DNA、RNA和蛋白质样本，可为制定个性化治疗方案提供有价值的信息。基因组学和蛋白质组学研究的进展，如下一代测序和质谱技术的发展，也增加了该市场的需求曲线。这些技术用于快速有效地分析大量生物数据。微阵列技术在研究、诊断和药物开发领域的应用正在迅速增加。生物芯片是微阵列技术的关键组成部分，用于研究基因表达和蛋白质相互作用。包括癌症、心血管疾病和糖尿病在内的慢性疾病发病率的上升也支持了这一市场。生物芯片用于诊断、治疗和监测这些疾病，由于人口老龄化和不健康的生活方式等因素，这些疾病正变得越来越普遍。芯片实验室和微流控技术的发展等技术进步也有助于该市场的增长。这些技术能够更快、更准确地分析生物样本，对研究和诊断至关重要。各国政府的大量投资也支持了这一市场。例如，美国政府发起了多项旨在推动基因组学研究和个性化医疗的倡议，预计这将促进市场需求。

研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于在全球范围内清晰地了解行业结构并评估竞争吸引力。此外，这些工具还对全球生物芯片市场的各个细分市场进行了全面评估。生物芯片行业的增长和趋势为本研究提供了整体方法。

市场细分：

生物芯片市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按类型

  • DNA芯片（癌症诊断和治疗、基因表达、SNP基因分型、基因组学、药物发现、农业生物技术、其他）
  • 蛋白质芯片（蛋白质组学、表达谱分析、诊断、HTS、药物发现、其他）
  • 芯片实验室（基因组学、IVD和POC、蛋白质组学、药物研发、其他）
  • 组织芯片
  • 细胞芯片

按最终用户分类

  • 生物技术和制药公司
  • 医院和诊断中心
  • 学术研究机构
  • 其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美、中东和非洲地区生物芯片市场的当前和未来需求。此外，报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。生物芯片市场的主要参与者包括雅培实验室、安捷伦科技公司、珀金埃尔默公司、Fluidigm公司、Illumina公司、通用电气医疗保健公司、Bio-Rad实验室公司、赛默飞世尔科技公司、LI-COR公司、分子设备有限责任公司。本节包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品发布和其他发展。

目 录

第一章：前言

  • 报告描述
    • 报告目标
    • 目标受众
    • 独特销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场调研流程
    • 市场调研方法

第二章：执行摘要

  • 市场亮点
  • 全球市场概况

第三章：生物芯片-行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按最终用途的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

第五章：全球生物芯片市场分析：按类型划分

  • 类型概述
  • 历史和预测数据
  • 按类型分析
  • DNA芯片（癌症诊断和治疗、基因表达、SNP基因分型、基因组学、药物发现、农业生物技术、其他）
  • 蛋白质芯片（蛋白质组学、表达谱分析、诊断、HTS、药物发现、其他）
  • 芯片实验室（基因组学、IVD和POC、蛋白质组学、药物研发、其他）
  • 组织芯片
  • 细胞芯片

第六章：全球生物芯片市场分析：按最终用途分类

  • 终端用途概述
  • 历史和预测数据
  • 按最终用途分析
  • 生物技术和制药公司
  • 医院和诊断中心
  • 学术研究机构
  • 其他

第七章 ：全球生物芯片市场分析：按地域划分

  • 地区前景
  • 地区介绍
  • 北美销售分析
    • 概述、历史和预测数据 销售分析
    • 北美细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据 销售分析
    • 欧洲销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据 销售分析
    • 亚太地区细分市场销售分析
    • 亚太地区各国销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据 销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据 销售分析
    • 中东及非洲地区销售分析
    • 中东及非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第八章 : 生物芯片企业竞争格局

  • 生物芯片市场竞争
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品发布
  • 其他发展

第九章 : 公司概况

  • 顶级公司市场份额分析
  • 市场集中度
  • Abbott Laboratories
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Agilent Technologies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • PerkinElmer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Fluidigm Corp.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Illumina Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • GE Healthcare
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Bio-Rad Laboratories Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • LI-COR Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Molecular Devices LLC
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

Product Code: VMR112111184

The global demand for Biochips Market is presumed to reach the market size of nearly USD 27.19 BN by 2030 from USD 8.91 BN in 2022 with a CAGR of 14.97% under the study period 2023 - 2030.

Biochips, also known as microarrays, are small devices made up of tiny microchips or glass slides that are used to study biological molecules such as DNA, RNA, and proteins. These devices have thousands to millions of microscopic spots, each containing a different biological molecule. These work by binding the biological molecules of interest to the spots on the chip's surface, which can then be analyzed using various methods, such as fluorescence, chemiluminescence, or mass spectrometry. By analyzing the signals from each spot on the chip, researchers can obtain a wealth of information about the biological samples being analyzed.

Market Dynamics:

The growing trend towards personalized medicine, which involves tailoring medical treatment to an individual's genetic makeup, is driving the demand for biochips. These are used to analyze DNA, RNA, and protein samples, which can provide valuable information for developing personalized treatment plans. Advancements in genomics and proteomics research, such as the development of next-generation sequencing and mass spectrometry technologies, are also adding to the demand curve of this market. These are used in technologies to analyze large amounts of biological data quickly and efficiently. The adoption of microarray technology is increasing rapidly in research, diagnostics, and drug development. Biochips are a key component of microarray technology, which is used to study gene expression and protein interactions. The increasing incidence of chronic diseases, including cancer, cardiovascular diseases, and diabetes, is also supporting this market. Biochips are used in the diagnosis, treatment, and monitoring of these diseases, which are becoming more prevalent due to factors such as ageing populations and unhealthy lifestyles. Technological advancements, such as the development of lab-on-a-chip and microfluidics technologies, are also assisting the growth of this market. These technologies allow for faster and more accurate analysis of biological samples, which is critical in research and diagnostics. Heavy investments from various Governments are also supporting this market. For example, the US government has launched several initiatives aimed at advancing genomics research and personalized medicine, which is expected to boost the demand.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biochips. The growth and trends of biochips industry provide a holistic approach to this study.

Market Segmentation:

This section of the biochips market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • DNA Chips (Cancer Diagnosis And Treatment, Gene Expression, SNP Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others)
  • Protein Chips (Proteomics, Expression Profiling, Diagnostics, HTS, Drug Discovery, Others)
  • Lab-On-Chip (Genomics, IVD & POC, Proteomics, Drug Discovery, Others)
  • Tissue Arrays
  • Cell Arrays

By End-Use

  • Biotechnology And Pharmaceutical Companie
  • Hospitals And Diagnostics Centers
  • Academic & Research Institutes
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Biochips market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the biochips market include Abbott Laboratories, Agilent Technologies, Inc., PerkinElmer, Inc., Fluidigm Corp., Illumina, Inc., GE Healthcare, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., LI-COR, Inc., Molecular Devices, LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BIOCHIPS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BIOCHIPS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 DNA Chips (Cancer Diagnosis And Treatment, Gene Expression, SNP Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others) Historic and Forecast Sales by Regions
  • 5.5 Protein Chips (Proteomics, Expression Profiling, Diagnostics, HTS, Drug Discovery, Others) Historic and Forecast Sales by Regions
  • 5.6 Lab-on-chip (Genomics, IVD & POC, Proteomics, Drug Discovery, Others) Historic and Forecast Sales by Regions
  • 5.7 Tissue Arrays Historic and Forecast Sales by Regions
  • 5.8 Cell Arrays Historic and Forecast Sales by Regions

6 . GLOBAL BIOCHIPS MARKET ANALYSIS BY END-USE

  • 6.1 Overview by End-use
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-use
  • 6.4 Biotechnology And Pharmaceutical Companie Historic and Forecast Sales by Regions
  • 6.5 Hospitals And Diagnostics Centers Historic and Forecast Sales by Regions
  • 6.6 Academic & Research Institutes Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL BIOCHIPS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE BIOCHIPS COMPANIES

  • 8.1. Biochips Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF BIOCHIPS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Agilent Technologies Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. PerkinElmer Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Fluidigm Corp.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Illumina Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. GE Healthcare
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Bio-Rad Laboratories Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Thermo Fisher Scientific Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. LI-COR Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Molecular Devices LLC
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • DNA Chips (Cancer Diagnosis And Treatment, Gene Expression, SNP Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others) Market Sales by Geography (USD MN)
  • Protein Chips (Proteomics, Expression Profiling, Diagnostics, HTS, Drug Discovery, Others) Market Sales by Geography (USD MN)
  • Lab-on-chip (Genomics, IVD & POC, Proteomics, Drug Discovery, Others) Market Sales by Geography (USD MN)
  • Tissue Arrays Market Sales by Geography (USD MN)
  • Cell Arrays Market Sales by Geography (USD MN)
  • Analysis Market by End-use (USD MN)
  • Biotechnology And Pharmaceutical Companie Market Sales by Geography (USD MN)
  • Hospitals And Diagnostics Centers Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Biochips Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biochips Report
  • Market Research Process
  • Market Research Methodology
  • Global Biochips Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • DNA Chips (Cancer Diagnosis And Treatment, Gene Expression, SNP Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others) Market Sales by Geography (USD MN)
  • Protein Chips (Proteomics, Expression Profiling, Diagnostics, HTS, Drug Discovery, Others) Market Sales by Geography (USD MN)
  • Lab-on-chip (Genomics, IVD & POC, Proteomics, Drug Discovery, Others) Market Sales by Geography (USD MN)
  • Tissue Arrays Market Sales by Geography (USD MN)
  • Cell Arrays Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Biotechnology And Pharmaceutical Companie Market Sales by Geography (USD MN)
  • Hospitals And Diagnostics Centers Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.